Last reviewed · How we verify
NCT06076460: ETEFVsCEF
Early Total Enteral Feeding Versus Convention Enteral Feeding in Preterm Infants 27-32 Weeks of Gestation
NA trial testing Early Total Enteral Feeding in Very Preterm Maturity of Infant in 183 participants. Completed in 10 January 2024.
10 January 2024
Quick facts
| Lead sponsor | Lady Hardinge Medical College |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 183 |
| Start date | 11 March 2022 |
| Primary completion | 10 January 2024 |
| Estimated completion | 10 January 2024 |
| Sites | 1 location across India |
Drugs / interventions tested
- Early Total Enteral Feeding
- Conventional Enteral Feeding
Conditions studied
- Very Preterm Maturity of Infant — all drugs for Very Preterm Maturity of Infant →
- Enteral Feeding Intolerance — all drugs for Enteral Feeding Intolerance →
Sponsor
Lady Hardinge Medical College
Who can join
Under 1 Hour, any sex, with Very Preterm Maturity of Infant or Enteral Feeding Intolerance. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of the study is to compare the time of attainment of full enteral feeds in preterm neonates between 27-32 weeks of gestation started on early total enteral feeding (ETEF) with those started on conventional enteral feeding (CEF).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06076460
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Very Preterm Maturity of Infant
Currently open trials in the same condition.
- NCT04239508 — Swiss Neonatal Network & Follow-up Group · recruiting
Other Lady Hardinge Medical College trials
Trials by the same sponsor.
- NCT05958160 — Modified Atkins Diet Versus Topiramate In Children With Epileptic Spasms Refractory To Hormonal Treatment: A Randomized · Phase 2, PHASE3 · unknown
- NCT06197269 — Efficacy And Safety Of Short Course Antibiotic Therapy In Preterm Neonates With Early Onset Sepsis · NA · completed
- NCT06090981 — Early Bolus Surfactant Replacement Therapy Versus Standard Care in Term Neonates With Meconium Aspiration Syndrome · NA · completed
- NCT06090968 — Umbilical Cord Milking Versus Immediate Cord Clamping in Full Term Neonates (≥ 37 Weeks) Requiring Resuscitation · NA · completed
- NCT04172311 — Modified Atkins Diet Versus Levetiracetam for Refractory Childhood Epilepsy · Phase 2, PHASE3 · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06076460 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Lady Hardinge Medical College
- Last refreshed: 13 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06076460.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing